Anthera Pharmaceuticals, Inc.
ANTH
$0.0001
$0.000.00%
OTC PK
| 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | 03/31/2017 | |
|---|---|---|---|---|---|
| Net Income | -23.39M | -26.87M | -30.19M | -40.36M | -55.00M |
| Total Depreciation and Amortization | 397.00K | 281.00K | 271.00K | 325.00K | 239.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -6.94M | -5.26M | -5.91M | -4.01M | 5.56M |
| Change in Net Operating Assets | -2.02M | -5.04M | -7.05M | -7.29M | -3.34M |
| Cash from Operations | -31.95M | -36.90M | -42.87M | -51.33M | -52.54M |
| Capital Expenditure | -- | -- | 186.00K | -104.00K | -766.00K |
| Sale of Property, Plant, and Equipment | 358.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 358.00K | -- | 186.00K | -104.00K | -766.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 19.03M | 18.25M | 16.26M | 17.24M | 19.24M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 80.00K | 17.00M | 17.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -156.00K | -156.00K | -156.00K |
| Cash from Financing | 19.03M | 18.25M | 16.19M | 34.09M | 36.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.57M | -18.65M | -26.49M | -17.35M | -17.23M |